Brought to you by 
Entelos closes $20mm IPO
Apr 2006
Executive Summary
US-based Entelos Inc., a biotech specializing in computer-generated, or in silico, laboratory technology, sold £11.4mm ($20mm) of stock in its initial public offering on the London Stock Exchange's AIM. It sold 13.8mm shares at 82.75 pence each.
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- ADMET
-
Drug Discovery Tools
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Entelos closes $20mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice